These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 6227154)

  • 1. [Role of microcirculatory pathology and chalone regulation of epidermal cell proliferation in the pathogenesis of psoriasis].
    Dosychev EA; Eletskaia LV; Moshkalova IA; Topol'nitskiĭ NF; Tret'iakova NN
    Vestn Dermatol Venerol; 1983 Aug; (8):13-6. PubMed ID: 6227154
    [No Abstract]   [Full Text] [Related]  

  • 2. [Effect of hemosorption on the anti-chalone properties of the blood serum of patients with psoriasis].
    Khvatov EV; Ketlinskiĭ SA; Tret'iakova NN; Simbirtsev AS; Shostka GD
    Vestn Dermatol Venerol; 1988; (4):10-2. PubMed ID: 2970719
    [No Abstract]   [Full Text] [Related]  

  • 3. [The beta-blocker effect of the blood serum in patients with psoriasis].
    Sokolovskiĭ EV; Raznatovskiĭ IM; Tret'iakova NN
    Vestn Dermatol Venerol; 1989; (7):6-7. PubMed ID: 2573218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cell growth inhibiting factors, epidermal chalone and interferon, on the proliferation of epidermal cells.
    Kariniemi AL
    Acta Derm Venereol Suppl (Stockh); 1977; 57(78):1-26. PubMed ID: 144394
    [No Abstract]   [Full Text] [Related]  

  • 5. [Blockade of adrenoreceptors--a mechanism for impairing the humoral and cellular regulation of the proliferation of epidermal cells in psoriasis].
    Raznatovskiĭ IM; Khvatov EV; Egorov VIa
    Biull Eksp Biol Med; 1988 Apr; 105(4):488-91. PubMed ID: 2965923
    [No Abstract]   [Full Text] [Related]  

  • 6. Epidermal G1-chalone and transforming growth factor-beta are two different endogenous inhibitors of epidermal cell proliferation.
    Richter KH; Schnapke R; Clauss M; Fürstenberger G; Hinz D; Marks F
    J Cell Physiol; 1990 Mar; 142(3):496-504. PubMed ID: 1968903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Epidermic and lymphocytary chalone receptors in psoriasis].
    Vignale RA; Lasalvia E; Espasandin J; Borras A
    Med Cutan Ibero Lat Am; 1983; 11(4):233-40. PubMed ID: 6314069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Epidermopoietin--a hypothetical psoriatogenic factor].
    Twardowski Z
    Przegl Dermatol; 1979; 66(1):103-8. PubMed ID: 154691
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pathogenesis of skin eruptions in psoriasis].
    Raznatovskiĭ IM; Tret'iakova NN; Khvatov EV
    Vestn Dermatol Venerol; 1988; (9):9-11. PubMed ID: 2975104
    [No Abstract]   [Full Text] [Related]  

  • 10. Chalone-induced inhibition in DNA synthesis of human psoriatic epidermal cells cultured in diffusion chambers in mice.
    Kariniemi AL
    Ann Clin Res; 1976 Oct; 8(5):340-5. PubMed ID: 136922
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cell culture model for the study of epidermal (chalone) homeostasis.
    Prunieras M; Delescluse C; Regnier M
    Pharmacol Ther; 1980; 9(3):271-95. PubMed ID: 6447881
    [No Abstract]   [Full Text] [Related]  

  • 12. [Current aspects of the pathogenesis of skin manifestations in psoriasis vulgaris].
    Braun-Falco O
    Hautarzt; 1976 Aug; 27(8):363-4. PubMed ID: 182658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biological activity of epidermal chalones in the presence of blood serum from patients with psoriasis].
    Tret'iakova NN
    Biull Eksp Biol Med; 1984 Jun; 97(6):754-5. PubMed ID: 6234950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of relationship between Langerhans cells, epidermal cell proliferation and epidermal G1 chalone.
    Schweizer J; Marks F
    Experientia; 1978 Sep; 34(9):1235-7. PubMed ID: 152716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Modifying effect of the blood serum of patients with psoriasis on the inhibitory activity of epidermal chalones].
    Dosychev EA; Ketlinskiĭ SA; Tret'iakova NN
    Vestn Dermatol Venerol; 1981 Mar; (3):18-20. PubMed ID: 6455018
    [No Abstract]   [Full Text] [Related]  

  • 16. [Immunomorphological analysis of G2-chalone localization during the process of rat epidermis histogenesis].
    Simbirtsev AS; Dyban PA
    Biull Eksp Biol Med; 1982 Jun; 93(6):106-7. PubMed ID: 6214289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psoriasis as a possible defect of the adenyl cyclase-cyclic AMP cascade. A defective chalone mechanism?
    Voorhees JJ; Duell EA
    Arch Dermatol; 1971 Oct; 104(4):352-8. PubMed ID: 4329804
    [No Abstract]   [Full Text] [Related]  

  • 18. [Suppression of epidermal cellular proliferation of normal human skin under exposure to epidermal chalones in vitro].
    Dosychev EA; Topol'nitskiĭ NF; Ketlinskiĭ SA
    Vestn Dermatol Venerol; 1980 Feb; (2):4-8. PubMed ID: 6444478
    [No Abstract]   [Full Text] [Related]  

  • 19. The potential of the essential fatty acid-deficient hairless rat as a psoriasis screening model for topical anti-proliferative drugs.
    Jensen M; Groth L; Hølmer G; Hansen HS; Fullerton A
    Skin Pharmacol Appl Skin Physiol; 2002; 15(6):401-13. PubMed ID: 12476014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disturbance by tumor promotors of epidermal growth control (chalone mechanism).
    Marks F; Grimm W; Krieg L
    Hoppe Seylers Z Physiol Chem; 1972 Dec; 353(12):1970-2. PubMed ID: 4346531
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.